A SPRY2 mutation leading to MAPK/ERK pathway inhibition is associated with an autosomal dominant form of IgA nephropathy
暂无分享,去创建一个
L. Larocca | A. Milillo | A. Amoroso | S. Miscia | M. Marchisio | M. Martini | S. Costanzi | F. Gurrieri | P. Lanuti | F. La Carpia | E. Sangiorgi | G. Vischini | Vanessa D'Urbano